Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alistair Grey

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Current Opinion in Urology|November 12, 2015
Multiparametric ultrasound in the diagnosis of prostate cancerAlistair Grey, Hashim U Ahmed
Translational Andrology and Urology|July 18, 2020
Prostate cancer biology & genomicsHayley Whitaker, Joseph O Tam, Martin J Connor, et al.
BJU International|May 14, 2019
Targeted biopsy of the prostate: does this result in improvement in detection of high-grade cancer or the occurrence of the Will Rogers phenomenon?Edward J Bass, Clement Orczyk, Alistair Grey, et al.
Diagnostics (Basel, Switzerland)|July 27, 2022
Differentiating False Positive Lesions from Clinically Significant Cancer and Normal Prostate Tissue Using VERDICT MRI and Other Diffusion ModelsSnigdha Sen, Vanya Valindria, Paddy J Slator, et al.
Contemporary Clinical Trials|November 8, 2017
The CADMUS trial - Multi-parametric ultrasound targeted biopsies compared to multi-parametric MRI targeted biopsies in the diagnosis of clinically significant prostate cancerAlistair Grey, Rebecca Scott, Susan Charman, et al.
Frontiers in Oncology|February 2, 2023
The potential of using circulating tumour cells and their gene expression to predict docetaxel response in metastatic prostate cancerCaitlin R Davies, Tianyu Guo, Edwina Burke, et al.
The Journal of Urology|August 8, 2019
Noninvasive Detection of Clinically Significant Prostate Cancer Using Circulating Tumor CellsLei Xu, Xueying Mao, Alistair Grey, et al.
BMJ Open|April 9, 2022
Histo-MRI map study protocol: a prospective cohort study mapping MRI to histology for biomarker validation and prediction of prostate cancerSaurabh Singh, Manju Mathew, Thomy Mertzanidou, et al.
The Journal of Urology|October 4, 2019
Reply by AuthorsLei Xu, Xueying Mao, Alistair Grey, et al.
Radiology|August 2, 2022
Avoiding Unnecessary Biopsy after Multiparametric Prostate MRI with VERDICT Analysis: The INNOVATE StudySaurabh Singh, Harriet Rogers, Baris Kanber, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Current Opinion in Urology|November 12, 2015
Multiparametric ultrasound in the diagnosis of prostate cancerAlistair Grey, Hashim U Ahmed
Translational Andrology and Urology|July 18, 2020
Prostate cancer biology & genomicsHayley Whitaker, Joseph O Tam, Martin J Connor, et al.
BJU International|May 14, 2019
Targeted biopsy of the prostate: does this result in improvement in detection of high-grade cancer or the occurrence of the Will Rogers phenomenon?Edward J Bass, Clement Orczyk, Alistair Grey, et al.
Diagnostics (Basel, Switzerland)|July 27, 2022
Differentiating False Positive Lesions from Clinically Significant Cancer and Normal Prostate Tissue Using VERDICT MRI and Other Diffusion ModelsSnigdha Sen, Vanya Valindria, Paddy J Slator, et al.
Contemporary Clinical Trials|November 8, 2017
The CADMUS trial - Multi-parametric ultrasound targeted biopsies compared to multi-parametric MRI targeted biopsies in the diagnosis of clinically significant prostate cancerAlistair Grey, Rebecca Scott, Susan Charman, et al.
Frontiers in Oncology|February 2, 2023
The potential of using circulating tumour cells and their gene expression to predict docetaxel response in metastatic prostate cancerCaitlin R Davies, Tianyu Guo, Edwina Burke, et al.
The Journal of Urology|August 8, 2019
Noninvasive Detection of Clinically Significant Prostate Cancer Using Circulating Tumor CellsLei Xu, Xueying Mao, Alistair Grey, et al.
BMJ Open|April 9, 2022
Histo-MRI map study protocol: a prospective cohort study mapping MRI to histology for biomarker validation and prediction of prostate cancerSaurabh Singh, Manju Mathew, Thomy Mertzanidou, et al.
The Journal of Urology|October 4, 2019
Reply by AuthorsLei Xu, Xueying Mao, Alistair Grey, et al.
Radiology|August 2, 2022
Avoiding Unnecessary Biopsy after Multiparametric Prostate MRI with VERDICT Analysis: The INNOVATE StudySaurabh Singh, Harriet Rogers, Baris Kanber, et al.
Pageof 2